GO:0003972 RNA ligase (ATP) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003972 RNA ligase (ATP) activity catalyzes ATP-dependent joining of a 3'-hydroxyl and a 5'-phosphate on ribonucleotide substrates, releasing AMP and diphosphate.
• The reaction proceeds through a covalent enzyme-(lysyl-N)-AMP intermediate and is used in RNA repair, tRNA splicing, and RNA modification pathways.
• RtcB is the best-characterized eukaryotic RNA ligase (ATP) enzyme and is conserved from bacteria to humans, where it functions in tRNA splicing and the unfolded protein response.
• Archaeal and thermophilic RNA ligases, such as those from Palaeococcus pacificus, provide structural and engineering insights into ATP-dependent RNA ligation.
• Dysregulation of RNA ligase (ATP) activity has been linked to Alzheimer's disease through RTP801-mediated interference with the tRNA ligase complex.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of RNA ligase (ATP) genes in disease and RNA biology.
Description
RNA ligase (ATP) activity (GO:0003972) is a molecular function that joins two ribonucleotide strands through an ATP-dependent reaction, producing a phosphodiester bond and releasing AMP and diphosphate. This activity is essential for RNA repair, tRNA splicing, and the maintenance of RNA integrity in organisms ranging from archaea to humans. Unlike DNA ligases, which primarily act on DNA substrates, RNA ligase (ATP) enzymes are specialized for RNA ends and often use a distinct covalent AMP intermediate to activate the 5'-phosphate for attack by a 3'-hydroxyl. Researchers study this term because it sits at the intersection of RNA processing, stress responses, and neurodegeneration, and because its dysregulation can contribute to disease. The discovery of new RNA ligases with unexpected substrate tolerance, such as R2D ligase, further highlights the diversity of this enzyme class.
RNA ligase (ATP) activity At A Glance
| GO ID | GO:0003972 |
|---|---|
| GO term | RNA ligase (ATP) activity |
| Ontology | molecular_function |
| Synonym | polyribonucleotide ligase activity; poly(ribonucleotide):poly(ribonucleotide) ligase (AMP-forming); polyribonucleotide synthase (ATP) activity; ribonucleic ligase activity |
| Major function | ATP-dependent joining of RNA 3'-hydroxyl and 5'-phosphate ends, releasing AMP and diphosphate |
| Reaction | ATP + (ribonucleotide)n-3'-hydroxyl + 5'-phospho-(ribonucleotide)m = (ribonucleotide)n+m + AMP + diphosphate |
| Representative enzymes | RtcB, archaeal ATP-dependent RNA ligases, thermophilic RNA ligases |
| Biological context | RNA repair, tRNA splicing, unfolded protein response, RNA modification |
What Is GO:0003972?
GO:0003972 RNA ligase (ATP) activity is defined as catalysis of the reaction: ATP + (ribonucleotide)n-3'-hydroxyl + 5'-phospho-(ribonucleotide)m = (ribonucleotide)n+m + AMP + diphosphate. In other words, the enzyme uses ATP to join a 3'-OH end of one RNA molecule to a 5'-phosphate end of another RNA molecule, forming a longer RNA strand while releasing AMP and diphosphate. This activity is synonymous with polyribonucleotide ligase activity, poly(ribonucleotide):poly(ribonucleotide) ligase (AMP-forming), polyribonucleotide synthase (ATP) activity, and ribonucleic ligase activity.
Why Is RNA ligase (ATP) activity Important in Cell Biology?
RNA ligase (ATP) activity is important because it maintains RNA integrity and enables precise RNA processing events that are essential for translation and cellular stress responses. In eukaryotes, the tRNA ligase complex, containing RtcB, is required for splicing tRNA introns and for the unfolded protein response, where it ligates HAC1 mRNA to produce a functional transcription factor. In archaea and thermophiles, ATP-dependent RNA ligases contribute to RNA repair and provide models for understanding enzyme mechanism and stability. Dysregulation of this activity has been implicated in Alzheimer's disease, where RTP801 interacts with the tRNA ligase complex and alters its RNA ligase activity. Thus, GO:0003972 is a focal point for studies of RNA biology, neurodegeneration, and therapeutic targeting.
• Maintains RNA integrity by sealing breaks in RNA molecules through ATP-dependent ligation.
• Required for tRNA splicing in eukaryotes, a process essential for mature tRNA production.
• Functions in the unfolded protein response by ligating HAC1 mRNA to enable stress-responsive transcription.
• Contributes to RNA repair pathways in archaea and bacteria, supporting survival under stress.
• Dysregulation is linked to Alzheimer's disease through RTP801-mediated interference with the tRNA ligase complex.
• Provides a target for engineering thermostable RNA ligases for biotechnology applications.
• Enables the development of novel RNA ligase enzymes with expanded substrate range, such as R2D ligase.
• Supports structural and mechanistic studies that reveal how ATP is used to activate RNA ends.
• Offers opportunities for CRISPR-based functional genomics of RNA repair and splicing genes.
• Informs therapeutic strategies for neurodegeneration and RNA-processing disorders.
Molecular Mechanism of RNA ligase (ATP) activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the two RNA ends that need to be joined.
RNA ligase (ATP) enzymes recognize a 3'-hydroxyl end and a 5'-phosphorylated end on ribonucleotide substrates. Structural studies of RtcB and archaeal RNA ligases show that the enzyme binds these ends in a defined active site that positions them for catalysis. The 5'-phosphate is essential for activation, while the 3'-hydroxyl serves as the nucleophile in the ligation reaction.
ATP-dependent activation via covalent intermediate
In simple terms: ATP is used to activate the 5'-phosphate through a temporary covalent bond with the enzyme.
The reaction begins with ATP binding and cleavage, transferring AMP to the enzyme to form a covalent enzyme-(lysyl-N)-AMP intermediate. This activated AMP is then transferred to the 5'-phosphate of the RNA substrate, creating a 5'-phospho-AMP intermediate that is primed for attack by the 3'-hydroxyl. This mechanism is shared with DNA ligases but adapted for RNA substrates.
Phosphodiester bond formation and product release
In simple terms: The two RNA ends are stitched together, and the byproducts AMP and diphosphate are released.
The 3'-hydroxyl attacks the activated 5'-phospho-AMP, forming a new phosphodiester bond and joining the two ribonucleotide strands. AMP and diphosphate are released as byproducts, completing the reaction. In RtcB, this step is coupled to a distinct catalytic mechanism that involves a 3'-phosphate intermediate, as revealed by structural and biochemical studies.
Cofactors and metal ion requirements
In simple terms: Some RNA ligases need metal ions to work properly.
Many ATP-dependent RNA ligases require divalent metal ions, such as Mg2+ or Mn2+, for catalysis. Archaeal RNA ligases show metal-dependent cleavage of 3'-terminal adenosine, indicating a role for metals in substrate handling. Thermophilic RNA ligases from Palaeococcus pacificus retain activity at high temperatures, and their metal preferences have been characterized.
Regulation and interaction partners
In simple terms: Other proteins can turn RNA ligase activity up or down.
The tRNA ligase complex is regulated by interaction partners such as RTP801, which dysregulates its RNA ligase activity in Alzheimer's disease. RtcB activity is also linked to the unfolded protein response, where its ligation of HAC1 mRNA is tightly controlled. These regulatory interactions provide potential targets for therapeutic intervention.
Key Genes Involved in GO:0003972 RNA ligase (ATP) activity
The following genes and proteins are experimentally implicated in RNA ligase (ATP) activity or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RTCB | Catalytic subunit of the tRNA ligase complex; performs ATP-dependent RNA ligation | Central enzyme for tRNA splicing and unfolded protein response; target for structural and functional studies |
| RTP801 | Interacts with the tRNA ligase complex and dysregulates its RNA ligase activity | Implicated in Alzheimer's disease; modulates RNA ligase activity |
| HAC1 | mRNA substrate ligated by RtcB during the unfolded protein response | Readout for RNA ligase (ATP) activity in stress response studies |
| DDX1 | RNA helicase component of the tRNA ligase complex | Assists in tRNA splicing and RNA ligation |
| FAM98B | Component of the tRNA ligase complex | Supports RtcB-mediated RNA ligation |
| CGI-99 | Component of the tRNA ligase complex | Required for efficient tRNA splicing |
| ASW | Archaeal ATP-dependent RNA ligase | Model enzyme for mechanistic studies of RNA ligation |
| R2D ligase | Novel DNA ligase with DNA-to-RNA ligation activity | Expands understanding of ligase substrate tolerance |
| TNA enzyme | Threose nucleic acid enzyme with RNA ligase activity | Provides insight into alternative nucleic acid ligation |
| P. pacificus RNA ligase | Thermophilic ATP-dependent RNA ligase | Model for thermostability and engineering |
| RtcB (bacterial) | Bacterial RNA ligase involved in RNA repair | Comparative studies of RNA repair pathways |
| RtcA | RNA ligase involved in RNA repair in bacteria | Functional partner in RNA repair |
| RtcB (archaeal) | Archaeal RNA ligase with ATP-dependent activity | Structural and biochemical model |
| tRNA ligase complex subunits | Multiprotein complex that performs tRNA splicing | Target for knockout and knock-in studies |
| RTP801 (human) | Stress-responsive protein that interacts with tRNA ligase complex | Disease-relevant regulator |
| HAC1 (yeast) | mRNA substrate for RtcB in unfolded protein response | Genetic model for RNA ligase function |
| RtcB (human) | Human RNA ligase essential for tRNA splicing | Therapeutic target in neurodegeneration |
| Archaeal RNA ligase | ATP-dependent RNA ligase from archaea | Mechanistic studies of 3'-terminal adenosine cleavage |
How Is RNA ligase (ATP) activity Regulated?
RNA ligase (ATP) activity is regulated at multiple levels. In eukaryotes, the tRNA ligase complex is subject to interaction with regulatory proteins such as RTP801, which can dysregulate its RNA ligase activity in Alzheimer's disease. The unfolded protein response controls RtcB-mediated ligation of HAC1 mRNA, linking RNA ligase activity to ER stress signaling. Additionally, the expression and stability of RtcB and its complex partners may be modulated by cellular stress and developmental cues. These regulatory mechanisms ensure that RNA ligation is coupled to appropriate cellular contexts.
RNA ligase (ATP) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RTP801 | Alzheimer's disease; dysregulation of tRNA ligase complex | Knockout or overexpression in neuronal cell lines |
| RTCB | tRNA splicing defects; unfolded protein response | CRISPR knockout in HEK293 or HeLa cells |
| HAC1 | ER stress response; cancer stress adaptation | Reporter assays in yeast or mammalian cells |
| tRNA ligase complex subunits | RNA processing disorders | Knock-in of tagged subunits for proteomics |
| Archaeal RNA ligase | RNA repair mechanisms | Thermophilic enzyme engineering |
Alzheimer's disease and neurodegeneration
RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer's disease, suggesting that altered RNA ligation contributes to neurodegeneration. This link positions RNA ligase (ATP) activity as a potential therapeutic target for Alzheimer's disease and related disorders.
RNA processing disorders and tRNA splicing defects
Defects in tRNA splicing, which depends on RtcB-mediated RNA ligase (ATP) activity, can impair translation and cellular homeostasis. Mutations affecting the tRNA ligase complex may lead to ribosomopathy-like phenotypes, although specific human diseases await further characterization.
Cancer and stress adaptation
The unfolded protein response, in which RtcB ligates HAC1 mRNA, is often hijacked by cancer cells to survive stress. Modulating RNA ligase (ATP) activity could therefore influence tumor stress adaptation, though direct evidence in cancer models remains limited.
From RNA ligase (ATP) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does RTCB loss affect tRNA splicing? | CRISPR knockout in human cell lines |
| Does RTP801 dysregulate RNA ligase activity? | Overexpression of RTP801 in neuronal cells |
| What is the catalytic mechanism of RtcB? | Point mutations in catalytic residues followed by biochemical assays |
| How does the tRNA ligase complex assemble? | Knock-in of epitope tags for affinity purification |
| Can thermophilic RNA ligases be engineered? | Directed evolution and knock-in in P. pacificus |
| Does RNA ligase activity affect stress response? | Reporter assays for HAC1 splicing |
How to Study the RNA ligase (ATP) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ligation assay | Enzymatic joining of RNA substrates | Mechanistic studies of RtcB and archaeal ligases |
| ATP hydrolysis assay | ATP consumption during ligation | Kinetic characterization of RNA ligases |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complexes | Active site mapping and inhibitor design |
| RNA-seq | Global RNA expression and splicing changes | Detecting tRNA splicing defects |
| tRNA sequencing | tRNA processing intermediates | Functional analysis of tRNA ligase complex |
| Mass spectrometry | Protein-protein interactions | Identifying tRNA ligase complex components |
| CRISPR knockout | Loss-of-function phenotypes | Testing causal roles of RNA ligase genes |
| Reporter assays | HAC1 mRNA splicing readout | Measuring unfolded protein response |
Biochemical ligation assays
In vitro ligation assays using synthetic RNA substrates and recombinant enzymes are used to measure ATP-dependent RNA ligase activity directly. These assays typically monitor the formation of longer RNA products by gel electrophoresis and can be coupled with ATP hydrolysis measurements.
Structural biology
X-ray crystallography and cryo-EM have revealed the architecture of RtcB and archaeal RNA ligases, including the active site and covalent AMP intermediate. Structural studies guide mutational analysis and inhibitor design.
RNA sequencing and tRNA profiling
RNA-seq and tRNA-specific sequencing can detect defects in tRNA splicing and RNA ligation in cells lacking RtcB or its partners. These methods quantify unspliced tRNA intermediates and other ligation-dependent RNA species.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry identifies components of the tRNA ligase complex and its regulatory interactors, such as RTP801. These approaches reveal how RNA ligase (ATP) activity is integrated into cellular networks.
How CRISPR Can Be Used to Study GO:0003972 RNA ligase (ATP) activity
Knockout
CRISPR knockout of RTCB or other tRNA ligase complex genes can abolish RNA ligase (ATP) activity, leading to defective tRNA splicing and impaired stress responses. These models are used to test the requirement for RNA ligation in cell viability and disease phenotypes.
Point Mutation
Point mutations in catalytic residues of RtcB or archaeal RNA ligases can dissect the mechanism of ATP-dependent ligation and the role of the covalent AMP intermediate. Such mutants are valuable for separating ligation activity from other functions.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous RTCB or complex subunits enables visualization and affinity purification of the tRNA ligase complex. This approach helps define its composition and dynamics in living cells.
Overexpression
Overexpression of RTP801 or other regulators can dysregulate RNA ligase (ATP) activity, modeling disease-associated perturbations such as those seen in Alzheimer's disease. Overexpression of wild-type or mutant RtcB can also rescue or exacerbate phenotypes in knockout backgrounds.
How EDITGENE Supports RNA ligase (ATP) activity Research
Researchers studying RNA ligase (ATP) activity-related genes often need to determine whether a candidate gene is causally involved in RNA processing, stress responses, or disease. EDITGENE provides CRISPR-based cell models and screening services to enable these functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for RNA ligase (ATP) activity research.
Frequently Asked Questions About RNA ligase (ATP) activity
What is RNA ligase (ATP) activity?
RNA ligase (ATP) activity (GO:0003972) is the ATP-dependent joining of a 3'-hydroxyl and a 5'-phosphate on ribonucleotide substrates, releasing AMP and diphosphate.
What genes are involved in RNA ligase (ATP) activity?
Key genes include RTCB, which encodes the catalytic subunit of the tRNA ligase complex, and RTP801, which regulates its activity.
What is the function of RtcB?
RtcB is an RNA ligase that catalyzes ATP-dependent ligation of RNA ends during tRNA splicing and the unfolded protein response.
How is RNA ligase (ATP) activity linked to Alzheimer's disease?
RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer's disease.
What is the reaction catalyzed by RNA ligase (ATP) activity?
The reaction is ATP + (ribonucleotide)n-3'-hydroxyl + 5'-phospho-(ribonucleotide)m = (ribonucleotide)n+m + AMP + diphosphate.
What are the synonyms for RNA ligase (ATP) activity?
Synonyms include polyribonucleotide ligase activity, poly(ribonucleotide):poly(ribonucleotide) ligase (AMP-forming), polyribonucleotide synthase (ATP) activity, and ribonucleic ligase activity.
Which organisms have RNA ligase (ATP) activity?
This activity is found in archaea, bacteria, and eukaryotes, including thermophiles such as Palaeococcus pacificus.
How can I study RNA ligase (ATP) activity in the lab?
Common methods include in vitro ligation assays, ATP hydrolysis assays, structural biology, RNA-seq, and CRISPR knockout models.
What diseases are associated with RNA ligase (ATP) activity?
Dysregulation has been linked to Alzheimer's disease, and defects in tRNA splicing may contribute to RNA processing disorders.
Does EDITGENE provide CRISPR models for RNA ligase research?
Yes, EDITGENE offers knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services for RNA ligase (ATP) activity studies.
Conclusion
GO:0003972 RNA ligase (ATP) activity is a fundamental molecular function that joins RNA ends through an ATP-dependent mechanism, with critical roles in tRNA splicing, RNA repair, and the unfolded protein response. Its dysregulation is implicated in Alzheimer's disease, and ongoing structural and biochemical studies continue to reveal new enzymes and regulatory mechanisms. CRISPR-based models and biochemical assays provide powerful tools to dissect this activity and its disease relevance.
References
- 1. Campoy-Campos G et al.. 2024. RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer's disease.. Nucleic Acids Res 52(18):11158-11176 PMID: 39268577
- 2. Moncan M et al.. 2023. Insights into the structure and function of the RNA ligase RtcB.. Cell Mol Life Sci 80(12):352 PMID: 37935993
- 3. Gundesø SE et al.. 2024. R2D ligase: Unveiling a novel DNA ligase with surprising DNA-to-RNA ligation activity.. Biotechnol J 19(3):e2300711 PMID: 38528369
- 4. Yoshinari S et al.. 2017. Cleavage of 3'-terminal adenosine by archaeal ATP-dependent RNA ligase.. Sci Rep 7(1):11662 PMID: 28912583
- 5. Wang Y et al.. 2021. A Threose Nucleic Acid Enzyme with RNA Ligase Activity.. J Am Chem Soc 143(21):8154-8163 PMID: 34028252
- 6. Hu Y et al.. 2024. Biochemical and structural insights into a 5' to 3' RNA ligase reveal a potential role in tRNA ligation.. Proc Natl Acad Sci U S A 121(42):e2408249121 PMID: 39388274
- 7. Shuman S. 2023. RNA Repair: Hiding in Plain Sight.. Annu Rev Genet 57:461-489 PMID: 37722686
- 8. Rousseau M et al.. 2024. Characterisation and engineering of a thermophilic RNA ligase from Palaeococcus pacificus.. Nucleic Acids Res 52(7):3924-3937 PMID: 38421610
